"10.1371_journal.pone.0103370","plos one","2014-08-01T00:00:00Z","Alex Thompson; Scott Devine; Mike Kattan; Andrew Muir","Department of Gastroenterology, St. Vincent's Hospital, Melbourne, VIC, Australia; Merck, Whitehouse Station, New Jersey, United States of America; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, United States of America; Duke University School of Medicine, Durham, North Carolina, United States of America","Conceived and designed the experiments: SD AT MK AM. Performed the experiments: SD AT MK AM. Analyzed the data: SD MK. Contributed reagents/materials/analysis tools: SD AT MK AM. Wrote the paper: SD AT MK AM.","Dr. Devine is an employee of Merck, Sharp & Dohme, Inc., the manufacturer of boceprevir. Drs Kattan, Thompson and Muir are or have been paid consultants of Merck, Sharp & Dohme, Inc., the manufacturer of boceprevir. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","08","Alex Thompson","AT",4,TRUE,4,4,2,4,TRUE,FALSE,FALSE,0,NA,FALSE
